A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer. Blanc-Durand F, Yaniz-Galende E, Llop-Guevara A, Genestie C, et al. Gynecol Oncol 2023;171:106-113.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Blanc-Durand F, Yaniz-Galende E, Llop-Guevara A, Genestie C, et al. A RAD51 functional assay as a candidate test for homologous recombination deficiency in ovarian cancer. Gynecol Oncol 2023;171:106-113.
PMID: 36868112